Modulation of T Cell Metabolism and Function through Calcium Signaling by Kelley M. Fracchia et al.
REVIEW ARTICLE
published: 11 October 2013
doi: 10.3389/fimmu.2013.00324
Modulation of T cell metabolism and function through
calcium signaling
Kelley M. Fracchia†, ChristineY. Pai † and Craig M.Walsh*





Tomasz Zal, University of Texas MD
Anderson Cancer Center, USA
Lucette Pelletier, Institute for National
and Health and Medical Research,
France
*Correspondence:
Craig M.Walsh, Department of
Molecular Biology and Biochemistry,
The Institute for Immunology,
University of California Irvine, 3215
McGaugh Hall, Irvine, CA
92697-3900, USA
e-mail: cwalsh@uci.edu
†Kelley M. Fracchia and ChristineY. Pai
have contributed equally to this work.
As a vital second messenger in the activation of lymphocytes, the divalent cation Ca2+ plays
numerous roles in adaptive immune responses. Importantly, Ca2+ signaling is essential for
T cell activation, tolerance of self-antigens, and homeostasis. Supporting the essential role
of Ca2+ signaling in T cell biology, the Ca2+ regulated protein phosphatase calcineurin is a
key target of pharmacologic inhibition for preventing allograft rejection and for autoimmune
therapy. Recent studies have highlighted the unique role of Stim1 and Orai1/2 proteins
in the regulation of store-operated/calcium release activated calcium (CRAC) channels in
the context of T cells. While Ca2+ is known to modulate T cell activation via effects on
calcineurin and its target, nuclear factor of activated T cells (NFAT), this second messen-
ger also regulates other pathways, including protein kinase C, calmodulin kinases, and
cytoskeletal proteins. Ca2+ also modulates the unique metabolic changes that occur dur-
ing in distinct T cell stages and subsets. Herein, we discuss the means by which Ca2+
mobilization modulates cellular metabolism following T cell receptor ligation. Further, we
highlight the crosstalk between mitochondrial metabolism, reactive oxygen species (ROS)
generation, and CRAC channel activity. As a target of mitochondrial ROS and Ca2+ regu-
lation, we describe the involvement of the serine/threonine kinase DRAK2 in the context
of these processes. Given the important roles for Ca2+ dependent signaling and cellular
metabolism in adaptive immune responses, the crosstalk between these pathways is likely
to be important for the regulation of T cell activation, tolerance, and homeostasis.
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INTRODUCTION
The adaptive immune system exhibits a wide potential for
responding to infectious agents encountered throughout a life-
time. Notably, T cells play a critical role in mounting an appropri-
ate response through the activation of their T cell receptor (TCR)
upon the recognition of specific antigen presented through the
major histocompatibility complex (MHC). This foreign peptide:
MHC complex activates a T cell with specificity for the for-
eign antigen, culminating in proliferation, and differentiation into
effector cells. In order to stimulate naïve T cells, ligation of the TCR
by antigen must be accompanied by a costimulatory signal. Cos-
timulation serves as a mechanism to modulate the strength of the
TCR signal and promote higher gene expression of immunomod-
ulatory cytokines like interleukin-2, as well as other factors that
facilitate T cell proliferation and differentiation (1, 2). When a
naïve T cell becomes activated, in the context of proper costim-
ulation, it executes developmental reprograming characterized by
rapid growth, proliferation, and acquisition of specialized effector
functions. Given that this is an energetically demanding process, T
cells undergo biochemical and biophysical reprograming to meet
these requirements (3).
A key mediator of T cell signaling is the divalent cation cal-
cium (Ca2+). Indeed, this second messenger is so important to T
cell biology that its downstream signaling serves as a vital phar-
macological target for the treatment of autoimmune disease and
the prevention of chronic allograft rejection (4). As with many
cell types, ligation of surface molecules that induce phospholipase
C leads to mobilization of intracellular calcium, with depletion
of Ca2+ from the endoplasmic reticulum (ER). However, it has
long been known that for sustained signaling downstream of Ca2+
release, T cells bear special plasma membrane Ca2+ channels that
promote the influx of extracellular Ca2+ (5). While beyond the
scope of the present review, recent work in several laboratories has
revealed that T cells and a select few other cell types, express plasma
membrane channels that are activated in response to depletion of
intracellular stores of Ca2+ (6). These calcium release activated
calcium (CRAC) channels are activated by Stim1, an ER mem-
brane protein that itself is induced upon depletion of Ca2+ stores
in ER. Major efforts are currently underway to understand the
biophysics of CRAC activation, and importantly, to determine if
manipulation of CRAC signaling may be of therapeutic benefit.
In the present review, we examine the link between cellu-
lar metabolism and calcium signaling in the context of T cells.
As described, Ca2+ modulates a variety of signaling cascades
downstream of the TCR and costimulatory receptors, many of
which impinge upon bioenergetic and biosynthetic pathways
needed for T cell clonal expansion, differentiation, and home-
ostasis. First, we briefly outline several important control points
that orchestrate cellular metabolic changes following TCR stim-
ulation. Next, we discuss the crosstalk between mitochondrial
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metabolism and CRAC activity, describing the influence of the
metabolic status of a given T cell on Ca2+ mobilization and sig-
naling. Finally, the impact of the release of mitochondrial reactive
oxygen species (ROS) on Ca2+ signaling is considered, with a focus
on the immunoregulatory serine/threonine kinase DRAK2 in this
process.
MODULATION OF CELLULAR METABOLISM FOLLOWING T
CELL ACTIVATION
Although one might consider metabolic regulation a mundane
housekeeping function of cells, it is becoming apparent that spe-
cific metabolic programs are induced in distinct T cell subsets and
developmental stages. For example, the metabolic status of naïve
T cells is significantly different from their activated counterparts.
Naïve T cells actively maintain a quiescent state through engage-
ment of both intracellular signaling pathways and cell extrinsic
signals (7), resulting in efficient use of available energy sources
(8). These quiescent lymphocytes maintain a catabolic state and
do not actively take up nutrients, nor do they secrete effector
cytokines (9). Once committed to a T cell fate in the thymus,
cellular metabolism plays a vital role in the development and pro-
liferation of double negative (DN) thymocyte precursors (11). In
DN thymocytes, both interleukin-7 (IL-7) and Notch prevent cell
death and promote pre-T cell development via activation of gly-
colytic metabolism and the Akt signaling pathway (12). Following
release from the thymus, antigenic stimulation of mature T cells
facilitates metabolic changes that support various bioenergetically
dependent processes needed for rapid clonal expansion (9). It is
proposed that T cells must shift from catabolic to anabolic metabo-
lism in order to rapidly proliferate, likely allowing them to respond
to microbial infection [(10) p. 2313]. Indeed, CD8 T cells have the
capacity to divide once every 4–6 h (13), a process that is highly
energy dependent. Naïve T cells appear to favor energetically effi-
cient processes such as the tricarboxylic acid (TCA) cycle linked to
the generation of ATP via oxidative phosphorylation (OXPHOS),
which results in roughly 30–32 ATP units per molecule of glu-
cose. In contrast, antigenically stimulated T cells rapidly shift to
a dependence on aerobic glycolysis, a less efficient process that
yields only two ATP units per molecule of glucose (14, 15). Acti-
vated T cells that fail to switch metabolic processes are rendered
anergic or undergo apoptosis (16), likely a consequence of failing
to accommodate the specific bioenergetic demands of prolifera-
tion and differentiation (17, 18). Thus, it is clear that the metabolic
status must match the needs of distinct T cell subsets and devel-
opmental stages in order for appropriate immune responses to be
generated.
With regard to the intracellular signaling involved in metabolic
regulation, it has long been appreciated that the mechanistic target
of rapamycin (mTOR) has a critical role in T cell activation and
metabolism (19). In the context of metabolism, mTOR serves to
integrate nutrient and immune signals, including the availability
of amino acids and oxygen, as well as the presence of extracel-
lular growth factors. mTOR then acts as an effector to modu-
late downstream cellular metabolic processes needed to meet the
demands of the cell upon stimulation (20). Such processes include
protein translational initiation via phosphorylation of S6K1 and
eIF4E (21), and lipid biosynthesis through the transcription factor
SREBP1 and the nuclear protein receptor PPARγ (22). It is cru-
cial, however, that mTOR does not become prematurely activated
until T cells are antigenically stimulated, as the quiescent metabolic
state of resting T cells appears to be important for their homeosta-
tic proliferation (23). As detailed later, the energy sensing protein
kinase AMPK acts as a master regulator of the metabolic status in
resting T cells. Induced by high levels of AMP, AMPK influences
mTOR activity through the tumor suppressor tuberous sclero-
sis complex (24). Comprised of TSC1 and TSC2, the tuberous
sclerosis complex itself negatively regulates mTOR activation (25)
and is crucial to maintaining homeostatic proliferation of naïve
T cells. Supporting this, Yang and colleagues observed that TSC1
deficient naïve T cells possess hyperactive mTOR activity, a result-
ing loss in quiescence, and a predisposition to undergo apoptosis
(26). Though naïve T cells do not initially require mTOR for TCR
induced activation, its absence by genetic deletion in mouse CD4
T cells yields a skewed differentiation toward induced T regulatory
cells over other effector T cell subsets (27). In addition, mTOR has
a central role in the regulation of both activated and long-lived
memory T cells as its genetic deletion or pharmacologic inactiva-
tion leads to diminished memory T cell activation and function
(22, 28, 29).
METABOLIC STATES IN DISTINCT T CELL SUBSETS
Naïve T cells utilize efficient oxidative metabolism to maintain
their quiescent state. Conversely, once T cells are stimulated by
antigen, they must quickly expand their numbers to eliminate
an antigenic challenge. This view is reminiscent of the Warburg
hypothesis, in which heightened glycolysis observed in cancer cells
is thought to allow for rapid tumor cell proliferation, particu-
larly under limiting oxygen tension (30). Alternatively, it has been
recently proposed that the switch to aerobic glycolysis is instead
necessary to support effector T cell differentiation. Pearce and col-
leagues demonstrated that blockade of glycolysis prevented the
expression of interferon gamma in activated T cells, but did not
impair clonal expansion (31). Moreover, the rapid recall response
observed in memory T cells, cells that often must respond quite
rapidly to antigenic rechallenge, is supported by enhanced respira-
tory and glycolytic capacity (32, 33). It remains to be determined if
this may reflect differential survival of unique subpopulations dur-
ing clonal expansion. Regardless, distinct metabolic processes are
clearly involved in providing for the energetic demands of unique
T cell subpopulations, with fatty acid oxidation (FAO) and aerobic
glycolysis playing significant roles.
FATTY ACID OXIDATION
In resting T cells that circulate in the periphery, FAO is the
default metabolic state, and the metabolism of these quiescent
cells is characterized by a need for basal energy utilization over
macromolecular biosynthesis (34). These naïve T cells utilize high
energy yielding OXPHOS processes, involving β-oxidation of fatty
acids and oxidation of glutamine and pyruvate via the TCA cycle
(34). Both naïve CD4 and CD8 T cells also rely on intrinsic IL-
7 to maintain homeostasis and quiescent survival (35). Loss of
IL-7 receptor (IL-7R) signaling results in defective T cell physi-
ology, characterized by decreased cell size/growth and markedly
impaired cell survival (36). The involvement of IL-7R signaling in
Frontiers in Immunology | T Cell Biology October 2013 | Volume 4 | Article 324 | 2
Fracchia et al. Calcium and T cell metabolism
the maintenance of peripheral T cell homeostasis is complex; it has
been recently found that IL-7R signaling must be intermittent and
not continuous, as the latter results in sensitization of naïve T cells
to cytokine induced cell death (37). While IL-7R signaling pro-
motes survival of quiescent peripheral T cells, and is required for
homeostatic proliferation under lymphopenic conditions, it alone
is not sufficient to induce naïve T cell activation and the metabolic
changes associated with this (38). Instead, with minimal mTOR
activity, resting T cells utilize other signaling factors to regulate
metabolic pathways. These factors include the nuclear receptors
PPARα and PPARγ, both of which regulate fatty acid metabolism
and inhibit activation upon TCR engagement (12, 39).
While an increase in glycolysis generally is observed in acti-
vated T cells, this is not always the case. Induced regulatory T cells
(iTreg), differentiated from peripheral CD4+ T cells, are a unique
subset of CD4+ T cells that suppress effector T cells and are vital to
immune peripheral tolerance (40). Following a lag phase heavily
dependent on glycolysis and glutaminolysis (28), T cells activated
in the context of extracellular signals that favor iTreg differentia-
tion (e.g., IL-2 and TGF-β) acquire a metabolic phenotype similar
to naïve T cells (41). Relying on lipid oxidation as their primary
source of energy, peripherally differentiated iTregs and their thymi-
cally derived nTreg counterparts have intermediate to low mTOR
activity (18). The distinct metabolic profile of Treg can be repli-
cated through in vitro culture with addition of glycolytic or mTOR
inhibitors, such as 2-deoxyglucose or rapamycin, respectively (12).
As with naïve T cells, PPARα and PPARγ are important for Tregs,
serving as fatty acid sensors, and promoting Foxp3 expression in
CD4+ T cells activated in the presence of TGF-β (42).
Fatty acid oxidation also plays a vital role in the maintenance of
memory T cell pools. Following clearance of an acute viral infec-
tion, the antiviral CD8+ effector T cell pool is radically depleted,
with a loss of 90–95% of virus specific CD8+ T cells (43). The
surviving cells in turn become long-lived memory T cells (44),
possessing unique metabolic characteristics when compared with
effector cells (45). Memory CD8+ T cells must be able to withstand
periods of both antigenic neglect and rapid antigen specific recall
through the acquisition of increased spare respiratory capacity
(SRC) through biogenesis of mitochondria and increased gly-
colytic flux (32). Thus, in contrast to their effector counterparts,
these long-lived CD8+ T cells have significantly enhanced SRC.
Memory CD8+ T cells share an analogous metabolic profile with
resting T cells and Tregs, primarily engaging in FAO to maintain
their survival and homeostasis (46). These metabolic processes are
maintained by IL-15 signaling, which facilitates the biogenesis of
mitochondria and expression of CPT1A, an enzyme responsible
for the rate-limiting step of FAO (32).
GLYCOLYSIS
As noted above, activated T cells switch their metabolic program-
ing to aerobic glycolysis upon antigenic stimulation (15, 47). This
may seem counterproductive, as the effective ATP output per glu-
cose molecule taken into the cell is roughly one fifteenth of the
units generated via OXPHOS (12). Instead, it has been proposed
that this switch is necessary to facilitate the rapid clonal expansion
required to eliminate a microbial infection (45). Growth factor
stimulation results in enhanced uptake of glucose through the
upregulation of the glucose transporter Glut1 on the surface of
cells, along with increased expression of the glycolytic enzymes
hexokinase and phosphofructokinase (14), processes activated in
T cells by TCR ligation (48). Costimulation through CD28 leads
to the induction of Akt, thereby enhancing glycolytic activity
in T cells (15), and the prevention of growth factor withdrawal
induced cell death (17). Supporting a crucial role for Akt in pro-
moting metabolic changes and the survival of activated T cells,
ectopic expression of an active form of Akt leads to increased
rates of glycolysis and T cell survival, even in the absence of CD28
signaling (49).
The AMP-dependent protein kinase AMPK serves a critical reg-
ulator of cellular metabolism, both in naïve and newly activated
T cells (Figure 1A). In resting cells, a high ratio of AMP to ATP
leads to elevated AMPK activity and diminished mTOR function.
TCR engagement activates LKB1 and in parallel, increases intra-
cellular Ca2+ stores, both leading to an increase in the expression
of AMPK (50). LKB1 positively regulates AMPK (51, 52), the
latter of which serves as an upstream regulator of TSC1 (52).
As TSC1 inhibits mTOR activity in naïve T cells through the
tuberous sclerosis complex, AMPK restricts the engagement of
metabolic programs associated with clonal expansion. Deletion of
the Tsc1 gene leads to metabolic alterations in T cells, most notably,
increases in glucose uptake and glycolytic flux (53). AMPK activ-
ity is positively influenced by calcium mobilization via its impact
on Ca2+ – calmodulin-dependent protein kinase kinase (CaMKK)
activity (50, 54). Thus, while AMPK may be associated with a qui-
escent T cell state, the TCR induced increase of cytosolic Ca2+
enhances AMPK activity (Figure 1B). This effectively conserves
ATP by inhibiting mTOR associated anabolic processes, and by
promoting OXPHOS (50, 55). With time, the resulting increase
in the ATP to AMP ratio leads to diminished AMPK activity, and
downstream restriction of mTOR is overcome, allowing the T cell
to shift its metabolism from FAO to OXPHOS (Figure 1C).
Upon successful engagement of their TCR and the costim-
ulation molecule CD28, the T cell begins to switch toward an
activated metabolic program, utilizing aerobic glycolysis, the phos-
phate pentose pathway (PPP), and glutaminolysis (18). Two tran-
scriptions factors that coordinate metabolic status following T
cell activation are Myc and HIF1α (28, 56). Induction of Myc
expression in activated T cells is largely responsible for metabolic
reprograming at a global gene transcriptome level, as its acute dele-
tion inhibited glycolysis, glutaminolysis, and provoked an overall
failure in cell growth and proliferation (28). Myc is also found
to intersect with the mTOR pathway, as its loss in activated T
cells led to reduced expression and phosphorylation of the down-
stream mTOR targets S6 and 4E-BP (28). mTOR itself, specifically
the mTOR complex 1 (mTORC1), is responsible for activating
two key metabolic transcriptional targets, HIF1α and SREBP1/2.
Specifically, HIF1α activates downstream targets involved in gly-
colysis and glucose uptake, while SREBP1/2 activates the PPP and
lipid biosynthesis (57). However, while SREBP activity is essen-
tial for metabolic reprograming in activated T cells (58), HIF1α
appears to play a more selective role in T cell subsets such as
Th17 cells (56, 59). It is likely that HIF1β serves a compensatory
role in HIF1α-deficient T cells, as loss of HIF1β leads to defective
glycolysis, survival, trafficking, and function of CD8+ T cells (60).
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FIGURE 1 |The modulation of cellular metabolism viaT cell receptor
(TCR) signaling. (A) In naïve T cells, fatty acid oxidation (FAO) is used to
maintain basal cellular metabolism. In this quiescent state, the absence of
TCR signaling leads to an elevated AMP to ATP ratio, resulting in sustained
AMPK and diminished mTOR activities. (B) Upon TCR stimulation by
antigen presenting cells (APC), along with CD28-mediated costimulation,
glycolysis is greatly enhanced, leading to a diminished AMP:ATP ratio.
During a lag phase that precedes T cell clonal expansion, LKB1 and CaMKK
(itself induced by high cytosolic Ca2+ levels) promote AMPK function
despite reduced AMP levels, and mTOR activity remains low via TSC1/2
mediated inhibition. (C) As T cells exit the lag phase, heightened levels of
ATP block AMPK activity, which results in the loss of TSC1/2 activity. This
allows for sustained mTOR function, and subsequent mTOR driven clonal
expansion and cell growth.
CALCIUMMOBILIZATION FOLLOWING TCR LIGATION
Having considered the modulation of cellular metabolism via TCR
proximal signaling pathways, we now turn our attention to calcium
mobilization, and how this signaling platform shapes the meta-
bolic response in T cells. As described in detail in this compendium
of reviews, TCR stimulation engages numerous signaling cas-
cades, resulting in cellular activation and proliferation. One such
molecule that is activated is phospholipase Cγ1 (PLCγ1), which
mediates the hydrolysis of phosphatidylinositol-3,4-bisphospahte
(PIP2) into inositol-1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG). Ca2+ release from ER stores is triggered upon the bind-
ing of IP3 to inositol trisphosphate receptor (IP3R) found on the
ER membrane. The two major ion channels that are known to
participate in Ca2+ release from the ER in response to agonist
stimulation are IP3Rs (61) and ryanodine receptors (RyRs) (62).
Mobilization of intracellular Ca2+ triggers store-operated Ca2+
entry (SOCE), primarily through calcium release activated Ca2+
(CRAC) channels (63). The binding of antigen/MHC to the TCR
complex results in the phosphorylation and activation of PLCγ1,
which then hydrolyzes phospholipids at the plasma membrane
to produce DAG and IP3. IP3 then binds to its respective recep-
tors in the ER, triggering calcium release into the cytosol. This
secondarily activates CRAC channels within the plasma mem-
brane, causing a rapid influx of extracellular calcium that sustains
high calcium levels required for T cell activation (64). Upon accu-
mulation, cytosolic calcium binds calmodulin (CaM), inducing a
conformational change in CaM that promotes its ability to inter-
act with and activate the protein phosphatase calcineurin (65).
Calcineurin dephosphorylates the cytoplasmic subunits (NFATc)
of nuclear factor of activated T cells (NFAT) transcription com-
plexes, exposing a nuclear localization sequence that results in their
import into the nucleus (66).
Cytosolic calcium is a universal second messenger affecting
a variety of cellular processes extending from short- to long-
term responses in immune cells (67). Unlike other intracellular
messengers, Ca2+ is neither synthesized nor metabolized. Rather,
Ca2+ storage and release are carefully regulated by a series of
channels and pumps that maintain precise Ca2+ concentrations
within distinct cellular compartments. In lymphocytes, activation
of immune receptors initiates a signaling cascade culminating in
the depletion of intracellular Ca2+ stores. Upon depletion, store-
operated calcium channels are activated, allowing Ca2+ to enter
into the cell, primarily through CRAC channels. The increase in
intracellular free calcium is essential for lymphocyte activation,
since the transcription factor families NFAT, NF-κB, and AP-1 are
all targets of Ca2+ mediated signaling (68). Remarkably, 75% of all
activation-regulated genes in T cells show a dependence on Ca2+
influx (68). Supporting this, loss of Ca2+ mobilization dramati-
cally reduces, and often prevents, T cell activation and proliferation
(68–70). Below, we detail the regulation of intracellular calcium
oscillation by CRAC channels and mitochondria, and describe
how Ca2+ influences the generation of and response to cellular
oxidants.
STORE-OPERATED CA2+ CHANNELS
Calcium release activated calcium channels comprise a widespread
and highly conserved Ca2+ entry pathway in cells such as lympho-
cytes, and are activated following the depletion of Ca2+ within the
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ER. This phenomenon is referred to as SOCE and CRAC activ-
ity is proportional to the amount of Ca2+ depletion within the
ER. Over the last decade, the key components of the CRAC chan-
nel machinery were identified as STIM1, the ER Ca2+ sensor and
Orai1/2, pore forming subunits of the CRAC channel (71). Deple-
tion of Ca2+ within the ER is detected by the Ca2+ sensors STIM1
and STIM2, resulting in the activation of store-operated calcium
channels. STIM1 and STIM2 are EF-hand containing single-pass
transmembrane proteins with both EF hands capable of bind-
ing Ca2+. STIM2 is thought to have a lower affinity for Ca2+
since STIM1-deficient mouse T cells and fibroblasts bear a severe
impairment in store-operated Ca2+ influx whereas a deficiency in
STIM2 has a less dramatic effect (72).
The luminal EF-hand of STIM1 senses Ca2+ depletion within
the ER and subsequently causes its oligomerization and translo-
cation toward the plasma membrane (73). STIM1 binds through
specialized ER-PM junctions, located within 25 nm of the plasma
membrane, to a component of the CRAC channel known as Orai1
(74). Once activated, CRAC channels have a remarkably selective
single channel conductance for Ca2+, and sensitive Ca2+ depen-
dent feedback regulation (75). Association of STIM1 and Orai1
depends on the involvement of STIM1 with the phosphoinositides
(PIs) of Orai1. Within STIM1, the cytosolic SOAR/CAD domain
contains an alpha-helical domain necessary for Orai1 binding (76,
77). Deletion of the SOAR/CAD domain abolishes store depletion-
induced clustering of Orai1 monomers and dramatically reduces
SOCE, suggesting this domain is required for the assembly of the
SOCE complex at ER-PM junctions (76, 77).
MITOCHONDRIAL CALCIUM BUFFERING AND HOMEOSTASIS
Mitochondria are recognized as essential calcium signaling
organelles. Through calcium buffering, mitochondria influence
CRAC channel activity (78). With the ability to sense Ca2+
microdomains, mitochondria are able to translocate to the
immunological synapse upon Ca2+ influx, leading to maximal
Ca2+ uptake. The positioning of mitochondria correlates with
the magnitude of local calcium entry via the reduction of Ca2+
dependent channel inactivation (79). By co-localizing near ER,
mitochondria are better suited to buffer cytosolic Ca2+.
Isolated mitochondria take up Ca2+ when supported by exoge-
nous electron transport chain (ETC) substrates (80). Although
it has been well known that mitochondria are endowed with a
complex array of Ca2+ transporters, the function of these trans-
porters was not well appreciated until the early 1990s when Pozzan,
Rizzuto and colleagues examined aequorin, a Ca2+ sensitive biolu-
minescent protein. They found that agonist-stimulated elevation
of cytosolic free Ca2+ results in a rapid and transient increase in
mitochondrial Ca2+, an increase blocked by pretreatment with
a mitochondrial uncoupler (81). Prior to this discovery, it was
believed that mitochondria failed to release much Ca2+ into the
cytosol and had little effect on InsP3-mediated Ca2+ release. It has
since become appreciated that mitochondrial matrix Ca2+ con-
centrations are crucial regulators of the Ca2+ dependent enzymes
of the TCA cycle (82). Mitochondria also play a vital role in the
gating of CRAC channels and do so through Ca2+ buffering (83).
Mitochondria act as Ca2+ buffers through uptake of Ca2+
released by IP3R on proximal ER membranes (Figure 2).
Mitochondria accomplish this through the ability to detect
changes in Ca2+ microdomains (84); Ca2+ uptake by mitochon-
dria occurs by mitochondrial Ca2+ uniporter (MCU) activity
across the inner mitochondrial membrane (85). This Ca2+ buffer-
ing is functionally significant as it modifies the Ca2+ dependent
inactivation of IP3R, ultimately leading to greater Ca2+ mobiliza-
tion. Mitochondria also deplete Ca2+ adjacent to the ER, resulting
in less available Ca2+ for transport into the ER via SERCA pumps.
Together, these events result in robust activation of CRAC chan-
nels (86, 87). It has been estimated that between 25 and 50% of
the Ca2+ released from ER is taken up by mitochondria, depen-
dent on cell type, and the Ca2+ release channel involved (88).
This Ca2+ uptake influences mitochondrial metabolic processes,
as three rate-limiting enzymes of the Krebs cycle are activated by
a rise in Ca2+ concentration, subsequently causing an increase
in mitochondrial ATP generation (89). These enzymes include
pyruvate dehydrogenase (PDH), NAD+-isocitrate dehydrogenase
(NAD-IDH), and 2-oxoglutarate dehydrogenase (82).
In addition to influencing CRAC channel gating, mitochon-
dria also influence STIM1 trafficking (90). Formation of STIM1
puncta below the plasma membrane is diminished, independently
of STIM1 oligomerization,upon strong mitochondrial depolariza-
tion. This is accomplished by the mitochondrial protein mitofusin
2 (MFN2), an outer mitochondrial membrane GTPase that cou-
ples mitochondrial energetic status to STIM1 migration (90). In
MFN2-deficient cells, mitochondrial depolarization fails to influ-
ence STIM1 trafficking and Ca2+ entry, suggesting that MFN2
confers sensitivity to mitochondrial depolarization. MFN2 assists
in tethering mitochondria to the ER and is abundant in the con-
tact sites between the two organelles, though the exact mechanism
through which these two organelles interact remains unclear (91).
It is speculated that the most likely function of the tethering is
to allow mitochondria to localize proximal to Ca2+ released from
ER. However, the question as to why STIM1 overexpression par-
tially rescues Ca2+ entry in MFN2 overexpressing cells has yet to
be answered.
While both ER and mitochondria serve as important intracel-
lular reservoirs of Ca2+, mitochondria utilize functionally distinct
Ca2+ transport mechanisms. Mitochondria possess a large elec-
trochemical gradient across their inner membrane (∆Ψm), which
acts as a driving force for the uptake of Ca2+ (92). Unlike with
ER, mitochondrial Ca2+ release occurs via ion exchangers, and
Ca2+ uptake is mediated via a selective ion channel (93). High cal-
cium levels, in combination with other signals, have been known
to trigger the opening of channels within the inner mitochondrial
membrane, ultimately resulting in cell death (94). The combined
action of these mechanisms allows for the rapid cycling of Ca2+
across the inner mitochondrial membrane (95).
REGULATION OF STIM1/ORAI SIGNALING BY OXIDATIVE
STRESS
Numerous physiological processes, including proliferation, and
cell death, are influenced by ROS (96, 97). To prevent oxidative
stress, the cell must maintain a balance between superoxide gen-
eration, a byproduct of oxidative energy production, and rapid
clearance of ROS. The latter is achieved through circulating antiox-
idants that act as ROS scavengers. Out of the ∼20 types of ROS,
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FIGURE 2 |The interplay between intracellular calcium mobilization
and cellular metabolism inT cells. Ligation of the T cell receptor (TCR)
by antigen (Ag) promotes opening of IP3R and depletion of ER Ca2+ via IP3,
itself generated by phospholipase Cγ1. Depletion of ER Ca2+ stores
promotes STIM1 interaction with Orai1, promoting oligomerization of Orai
monomers, thus forming CRAC channels. The resultant increase in
cytosolic Ca2+ promotes its entry into the mitochondrial matrix via the
mitochondrial calcium uniporter (MCU). Elevated matrix Ca2+ enhances the
activity of key tricarboxylic acid cycle (TCA) enzymes, leading to elevated
oxidative phosphorylation (OXPHOS), and ATP generation. Reactive
oxygen species (ROS) byproducts of OXPHOS enhance TCR proximal
signaling by inhibiting tyrosine phosphatase activity. Elevated cytosolic
ROS governs CRAC activity by ROS mediated modification of cysteine
residues exposed on Orai1.
hydrogen peroxide (H2O2) appears to be the major contributor
to oxidative damage (96). Of interest here, it has been found
that oxidative stress regulates STIM1/Orai1 signaling (98–100).
CRAC channels, under the action of STIM1, are stimulated by
micromolar concentrations of H2O2 (98–100). Altered calcium
signaling during oxidant stress is attributed to a reduction in the
Ca2+ binding affinity of STIM1 due to a modification involving its
cysteine 56, ultimately resulting in constitutive CRAC activation
(100). Upon exposure to ROS, STIM1 becomes S-glutathionylated,
thereby triggering its oligomerization and translocation to the
plasma membrane (100). Alternatively, Grupe and colleagues
demonstrated that H2O2 enhanced the CRAC current, ICRAC-
mediated Ca2+ influx by activating IP3R independent of Orai1
(99). Regardless of the route of entry, both groups demonstrate
that an increase an ROS leads to enhanced Ca2+ entry into the
cell. While several studies support the hypothesis that ROS posi-
tively stimulate CRAC channel activity by triggering the oligomer-
ization of STIM1, Bogeski and colleagues report that oxidation
via H2O2 specifically blocks the activation of Orai1 channels in
human T helper lymphocytes (98). It is speculated that the oxi-
dation of the cysteine, found within the extracellular loop of
Orai1, may lock the channel in the closed conformation. Nev-
ertheless, cells with an SOCE deficiency are more susceptible to
oxidative stress. Despite having an up-regulated basal antioxidant
response, STIM1-deficient mouse embryonic fibroblasts experi-
ence an imbalance of ROS production and detoxification upon
addition of exogenous oxidants (101). Henke and colleagues con-
clude that functional SOCE machinery is required to balance ROS
production and the cellular antioxidant defense system. Collec-
tively, these studies support the notion that the cellular oxidative
stress response is influenced through a dynamic interplay between
ROS balance and Ca2+ influx.
OXIDANT DEPENDENCE OF T CELL ACTIVATION
Oxidative stress is provoked by an imbalance between the pro-
duction of mitochondrial superoxide and insufficient scavenging
of ROS, ultimately resulting in a wide range of pathological con-
ditions (102). The dynamics of ROS production and scavenging
can be detected using several fluorescent dyes, including reduced
forms of ethidium bromide (DHE) (103), fluorescein (DCFDA)
(104, 105), rhodamine (DHR) (106), and hydroethidine (HE)
(107). These dyes remain relatively non-fluorescent until they are
oxidized by ROS, and their unquenched fluorescence correlates
with increased oxidation. These intracellular dyes provide sensi-
tive probes for multiple reactive species and allow for the detection
of fluorescent products using fluorimetry and flow cytometry. In
T cells, DCFDA, DHR, and DHE have been utilized to examine
ROS production from a variety of stimuli including mitogens
(108), viral and bacterial superantigen (109, 110), and TCR peptide
agonists (111, 112). ROS generation has been observed following
stimulation of T cells by other ligands including TGF-β, insulin,
angiotensin II, and EGF (113–116). Collectively, these studies sug-
gest that ROS function as secondary messengers necessary for
complete T cell activation. Superoxide is generated from the mito-
chondrial ETC through complexes I, II, and III (117). Complexes I
and II emit superoxide into the mitochondrial matrix, upon which
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superoxide dismutase 2 (SOD2) converts it into hydrogen peroxide
(H2O2). In contrast, complex III emits superoxide into both the
matrix and intermembrane spaces. Intermembrane-space super-
oxide is capable of reaching the cytosol through voltage-dependent
anion channels (VDAC) without conversion into H2O2 (118, 119).
Recently, Sena et al. reported that blocking mitochondrial ROS,
specifically generated at complex III, results in the inhibition of
CD3/CD28 induced IL-2 expression. Additionally, extracellular
calcium influx and subsequent Ca2+ uptake by mitochondria
were both required for mitochondrial ROS production (120).
These findings support the hypothesis that complex III produced
mitochondrial ROS, a byproduct of mitochondrial metabolism,
facilitate T cell activation and functionality. However, the mecha-
nisms through which oxidants may regulate T cell responses upon
stimulation remain poorly defined. Importantly, the timing and
subcellular localization of ROS generation are likely of greater
influence in T cell responses than overall redox balance (102,
121, 122). ROS clearly play key roles in modulating T cell acti-
vation and differentiation, but vital details regarding the influence
of these oxidants on specific signaling molecules remain to be
clarified.
DRAK2 AS A AN INTERMEDIARY IN CALCIUM AND
METABOLIC SIGNALING IN T CELLS
One molecule expressed in T cells that may potentially link
calcium and ROS signaling to cellular metabolic regulation is
DRAK2/STK17B. DRAK2 is a serine/threonine kinase of the death
associated protein kinase (DAPK) family (123), which is com-
prised of five known members (DAPK1, DAPK2, DAPK3, DRAK1,
and DRAK2). All of these kinases are capable of inducing cell death
when ectopically expressed in cells, and the prototype DAPK1
possesses a calmodulin regulatory domain that, through binding
to calmodulin/Ca2+, regulates its catalytic activity (124). While
DRAK2 lacks a calmodulin binding domain, like other DAPK fam-
ily members, DRAK2 has been shown to induce apoptosis upon
overexpression in cell lines (125), and its phosphorylation and
nuclear translocation participates in ultraviolet light induced cell
death (126).
Although broadly expressed at low levels (127), DRAK2 expres-
sion is enriched in cells of hematopoietic origin (128). Loss of
expression by virtue of a germline deletion of the Drak2 gene
leads to hyperactive Ca2+ mobilization in T cells, especially under
suboptimal TCR stimulus conditions (128, 129), supporting the
hypothesis that DRAK2 acts as a negative regulator of TCR sig-
naling (130). The notion that DRAK2 serves as a rheostat in
calcium signaling following TCR signaling is supported by the
finding that it is itself activated by calcium mobilization, and
that its ectopic expression in double positive thymocytes raises
the threshold for both negative and positive selection (131, 132).
Enigmatically, loss of the Drak2 gene leads to diminished autoim-
mune susceptibility, with reduced clinical severity observed in
animal autoimmune models for multiple sclerosis (experimental
autoimmune encephalomyelitis) and type I diabetes-prone non-
obese diabetic (NOD) mice (129, 133–135). The reduced EAE
susceptibility is due, at least in part, to diminished survival of acti-
vated effector T cells, perhaps a consequence of impaired calcium
homeostasis (133–135).
Using a mass spectrometry based approach, we determined that
DRAK2 possesses several autophosphorylation sites, most notably
Ser10, Ser12, and Ser351. Using antibodies specific for phospho-
rylation at Ser12, it was found that TCR stimulation induces
DRAK2 Ser12 autophosphorylation (131), and this requires entry
of extracellular Ca2+ into T cells. The SERCA inhibitor thapsigar-
gin was found to potently induce DRAK2 autophosphorylation on
Ser12, supporting the hypothesis that ER store-operated calcium
entry modulates DRAK2 catalytic activity. Recent studies have
revealed that TCR induced DRAK2 activation is highly dependent
on CRAC function, as DRAK2 was poorly activated following anti-
genic stimulation in Orai2-deficient T cells (136). Using a panel of
small molecule inhibitors and RNA interference approaches, it was
found that DRAK2 activation by antigenic stimulation requires
protein kinase D (PKD).
Curiously, DRAK2 catalytic activity in activated T cells also
depends on mitochondrial ROS, as antioxidants blocked Ser12
autophosphorylation (136). Since the electron transport com-
plex III inhibitor FCCP led to Ser12 phosphorylation indepen-
dent of antigenic stimulation of T cells, these findings demon-
strate that ROS are both necessary and sufficient to promote
DRAK2 catalytic activity. PKD activity is itself subject to activa-
tion by mitochondrial ROS (137, 138), and thus ROS induced
by enhanced mitochondrial respiration that results from TCR
stimulation likely participates in PKD-mediated DRAK2 activa-
tion (Figure 3). The specific nature of the interaction between
mitochondrial ROS and DRAK2’s substrates is poorly understood.
FIGURE 3 | Regulation of DRAK2 activity inT cells via Ca2+-induced
respiratory burst. TCR induced Ca2+ depletion from ER stores results in
opening of CRAC channels. This high cytosolic [Ca2+] promotes the
induction of TCA cycle and OXPHOS in mitochondria, the latter of which
release ROS as an OXPHOS byproduct. In addition to inhibiting
phosphatases, ROS activate PKD, which itself binds to and activates
DRAK2 (likely through transphosphorylation on DRAK2). DRAK2 then
impacts Ca2+ signaling by altering SERCA activity (hypothetical), or other
unknown substrates.
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However, as DRAK2-deficient T cells bear enhanced CRAC activity
(136), and DRAK2-transgenic thymocytes have diminished Ca2+
mobilization following TCR stimulation (132), it is likely that
DRAK2 may phosphorylate an intermediate in CRAC signaling.
DRAK2 has been shown to phosphorylate S6K1 (139), an impor-
tant target of mTOR and of TCR signaling that impacts cellular
metabolism (22, 57, 140). Thus, DRAK2 may itself serve as an
important link between calcium and mTOR signaling, impacting
the differentiation and survival of T cell subsets selectively required
for immune responsiveness.
CONCLUSION
Research into the regulation of CRAC activity, and the unique
involvement of metabolic signaling in T cells, has been intense
over the last several years. It is becoming quite evident that both
signaling paradigms are highly regulated and vital to T cell activa-
tion, differentiation, and homeostasis. These pathways also appear
to play selective roles in distinct T cell subsets, with the potential
that manipulation of such pathways could influence the balance
between immunity vs. self-tolerance in different disease states.
A significant challenge to immunologists is to develop selective
therapies to influence this balance. In the case of autoimmune dis-
orders, the difficulty is to block autoreactive T cell function without
promoting general immunosuppression. In the case of chronic
microbial pathogen infections and cancer, therapeutic approaches
to reinvigorate antimicrobial or anti-tumor T cell responsiveness
are highly sought after. It is thus imperative that novel methods are
considered to influence the appropriate immune response. Given
the unique crosstalk between calcium mobilization and bioener-
getic metabolism, there may be an opportunity to uniquely affect
the outcome of immune therapies by targeting the molecules that
mediate this crosstalk.
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